Skip to main content

Laying siege to beta-amyloid, the key protein in Alzheimer’s disease



Natalia Carulla
Research Associate
Tel.+34 93 40 37123


Press & Communications Section Head
Tel.+34 93 40 37255

Scientists at IRB Barcelona in collaboration with researchers at the University of Barcelona observe that aggregates of 20 to 100 units of beta-amyloid have a structure that is the most harmful to neurons.

This is the first time that a method allows scientists to monitor aggregation while simultaneously detect a structural pattern responsible for the toxicity of beta-amyloid aggregation.

The researchers state that these studies are a step towards finding a therapeutic target for a disease which, to date, has no treatment.

The peptide —a small protein— beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the onset and development of the disease. The main obstacle impeding such confirmation is that beta-amyloid is not harmful when found in isolation but only when it aggregates, that is when it self-assembles to form the so-called amyloid fibrils
“We are not dealing with a single target, beta-amyloid alone, but with multiple ones because each aggregate of peptide, which can go from two units to 3,000 is a potential target. Determining the aggregate responsible for neuronal death is extremely complex and is one of the key issues for confirming or rejecting the hypothesis regarding beta-amyloid,” explains Natàlia Carulla, scientist at the Institute for Research in Biomedicine (IRB Barcelona) and principal investigator of the study published today in the scientific journal ACS Chemical Biology. In their latest work, Carulla and collaborators describe a technique that has allowed them, for the first time, to distinguish different types of beta-amyloid aggregates formed during aggregation and in parallel to establish which is most toxic. The study provides further evidence in support of the hypothesis that neuronal death is caused by intermediate aggregates of beta-amyloid and reveals that the development of structure within these aggregates determines their ability to cause neuronal death.
The harmful forms of beta-amyloid
The study shows that the most toxic aggregates are those formed by 20 to 100 units of beta-amyloid, known as intermediate aggregates or precursor aggregates of beta-amyloid fibrils. In contrast, the smaller aggregates of beta-amyloid and the amyloid fibrils, which can contain up to 3,000 units of the peptide, do not cause neuronal death. 
The scientists treated cultures of mouse neurons with samples obtained at different times of the aggregation process. The point at which they observed the highest neuronal death, reaching about 60%, occurred when cells were exposed to intermediate aggregates of beta-amyloid that had developed a certain degree of structure. The experiments with mouse neurons were performed in collaboration with Eduardo Soriano’s team at the University of Barcelona, they prepared neuronal cultures from the hippocampus, the brain region in which neuronal lost is first observed in Alzheimer’s disease.

“The technique that we have set up allows us to detect how the structure within these aggregates increases, that is to say, how the aggregates take shape and how they get organized. We observed that maximum toxicity occurs when they have acquired a given degree of structure, a certain rigid part in the aggregate,” explains Carulla.

The scientists uphold that this is precisely one of the most promising results of the study presented today. “We can see structure, organization and common pattern and therefore the hope is that if we manage to characterize this pattern, we will be able to look for and design therapeutic molecules that prevent their formation or cause their disruption” says first author of the article Bernat Serra-Vidal, whose PhD thesis was based on this work.

Also Parkinson’s disease and type 2 diabetes
Furthermore, the researchers explain that the tools developed to study beta-amyloid aggregation could be used to examine the aggregation of other proteins that are associated with conditions such as Parkinson’s disease, Huntington’s disease, and type 2 diabetes. 
Reference article:

Hydrogen/Deuterium Exchange-Protected Oligomers Populated during Aβ Fibril Formation Correlate with Neuronal Cell Death

Bernat Serra-Vidal, Lluís Pujadas, Daniela Rossi, Eduardo Soriano, Sergio Madurga,and Natàlia Carulla

ACS Chem. Biol. (2014): 10.1021/cb500621x

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).